13 Feb CHO Plus
Lawrence Forman, Founder and CEO
April 15 | 10:00am | Salone dei Cavalieri, Section 2
San Francisco, CA
(Private)
CHO Plus, Inc. is a privately held company founded in 2014 to address the high costs and capacity issues facing therapeutic manufacturers of protein and viral vectors. We have developed cutting-edge technologies for creating high-productivity GMP-compliant mammalian cell lines. Specifically, we have applied our approach to engineering HEK-293 cells for viral vector production that are capable of greater than 15-fold AAV productivity and with up to 55% full capsids. We have developed a stably transfected, inducible AAV packaging cell line with similar performance. Stable, inducible AAV producer cell lines are under development. Our technologies will lower production costs, improve product quality, and improve manufacturing efficiency leading to consistent supply chain reliability.
